Oak Thistle LLC Purchases Shares of 25,409 Agilent Technologies, Inc. $A

Oak Thistle LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 25,409 shares of the medical research company’s stock, valued at approximately $3,457,000. Agilent Technologies accounts for approximately 0.5% of Oak Thistle LLC’s portfolio, making the stock its 18th biggest holding.

A number of other hedge funds have also recently bought and sold shares of the stock. Bridgefront Capital LLC bought a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $1,323,000. Envestnet Asset Management Inc. boosted its stake in shares of Agilent Technologies by 3.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after acquiring an additional 22,498 shares during the period. Wellington Management Group LLP boosted its stake in shares of Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after acquiring an additional 433,342 shares during the period. CCLA Investment Management boosted its stake in shares of Agilent Technologies by 10.5% during the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after acquiring an additional 97,312 shares during the period. Finally, Osaic Holdings Inc. boosted its stake in shares of Agilent Technologies by 35.5% during the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after acquiring an additional 17,817 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Price Performance

Shares of NYSE A opened at $113.78 on Wednesday. The stock has a market capitalization of $32.15 billion, a PE ratio of 25.12, a P/E/G ratio of 2.43 and a beta of 1.30. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The business has a fifty day moving average price of $120.42 and a two-hundred day moving average price of $134.37. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on A. Morgan Stanley reduced their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Barclays reduced their target price on Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. HSBC initiated coverage on Agilent Technologies in a research note on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Finally, The Goldman Sachs Group initiated coverage on Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $161.20.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.